Implantable cardioverter defibrillators and quality of life: Results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study

Archives of Internal Medicine

Volumn 167, Issue 20, 2007, Pages 2226-2232

  Passman, Rod ^a,d   Subacius, Haris ^a   Ruo, Bernice ^a   Schaechter, Andi ^a   Howard, Adam ^a   Sears, Sam F ^b,c   Kadish, Alan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c EAST CAROLINA UNIVERSITY   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL EVALUATION; COMPARATIVE STUDY; DEFIBRILLATOR; FEMALE; HEART DEPOLARIZATION; HEART EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 36; UNITED STATES;

ADULT; AGED; CARDIOMYOPATHIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 36148986404     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.167.20.2226     Document Type: Article

References (25)

1. Al-Khatib SM, Sanders GD, Mark DB, et al. Implantable cardioverter defibrillators and cardiac resynchronization in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am Heart J. 2005;149(6):1020-1034.
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverterdebrillator for congestive heart failure. N Engl J Med. 2005;352(3):225-237.
3. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med. 1996;334(13):835-840.
4. Kadish A, Dyer A, Daubert JP, et al; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. 2004;350(21):2151-2158.
5. Ware J Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
6. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living With Heart Failure Questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017-1025.
7. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY: Oxford University Press; 2003.
8. Raudenbush S, Bryk A. Hierarchical Linear Models: Applications and Data Analysis Methods. 2nd ed. Thousand Oaks, CA: Sage Publications; 2002.
9. Bennett SJ, Oldridge NB, Eckert GJ, et al. Comparison of quality of life measures in heart failure. Nurs Res. 2003;52(4):207-216.
10. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? evidence for a "trial effect." J Clin Epidemiol. 2001;54(3):217-224.
11. May CD, Smith PR, Murdock CJ, Davis MJ. The impact of the implantable cardioverter defibrillator on quality-of-life. Pacing Clin Electrophysiol. 1995;18(7):1411-1418.
12. Heller SS, Ormont MA, Lidagoster L, Sciacca RR, Steinberg S. Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol. 1998;21(6):1207-1215.
13. Morris PL, Badger J, Chmielewski C, Berger E, Goldberg RJ. Psychiatric morbidity following implantation of the automatic implantable cardioverter defibrillator. Psychosomatics. 1991;32(1):58-64.
14. Hegel MT, Griegel LE, Black C, Goulden L, Ozahowski T. Anxiety and depression in patients receiving implanted cardioverter-defibrillators: a longitudinal investigation. Int J Psychiatry Med. 1997;27(1):57-69.
15. Sears SF Jr, Conti JB. Quality of life and psychological functioning of ICD patients. Heart. 2002;87(5):488-493.
16. Namerow PB, Firth BR, Heywood GM, Windle JR, Parides MK. Quality-of-life six months after CABG surgery in patients randomized to ICD versus no ICD therapy: findings from the CABG Patch Trial. Pacing Clin Electrophysiol. 1999;22(9):1305-1313.
17. Schron EB, Exner DV, Yao Q, et al. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. 2002;105(5):589-594.
18. Irvine J, Dorian P, Baker B, et al. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144(2):282-289.
19. Mark DB, Nelson CL, Anstrom KJ, et al. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 2006;114(2):135-142.
20. Burke JL, Hallas CN, Clark-Carter D, White D, Connelly D. The psychosocial impact of the implantable cardioverter defibrillator: a meta-analytic review. Br J Health Psychol. 2003;8(Pt 2):165-178.
21. Lüderitz B, Jung W, Deister A, Marneros A, Manz M. Patient acceptance of the implantable cardioverter defibrillator in ventricular tachyarrhythmias. Pacing Clin Electrophysiol. 1993;16(9):1815-1821.
22. Walker RL, Campbell KA, Sears SF, et al. Women and the implantable cardioverter defibrillator: a lifespan perspective on key psychosocial issues. Clin Cardiol. 2004;27(10):543-546.
23. Wathen MS, DeGroot PJ, Sweeney MO, et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverterdefibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (Pain-FREE Rx II) trial results. Circulation. 2004;110(17):2591-2596.
24. Burns JL, Serber ER, Keim S, Sears SF. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida patient acceptance survey. J Cardiovasc Electrophysiol. 2005;16(4):384-390.
25. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF. Measurement of patient fears about implantable cardioverter defibrillator shock: an initial evaluation of the Florida shock anxiety scale. Pacing Clin Electrophysiol. 2006;29(6):614-618.